Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial

Схожие документы

• Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery
  по: Comstock, Timothy L, et al.
  Опубликовано: (2011)
• Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use
  по: Amon, Michael, et al.
  Опубликовано: (2012)
• A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgery
  по: Salinger, Clifford L, et al.
  Опубликовано: (2015)
• Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop
  по: Coffey, Martin J, et al.
  Опубликовано: (2013)
• Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies
  по: Fong, Raymond, et al.
  Опубликовано: (2019)